Clinical Trial Update: A Clinical Study to Investigate the Efficacy of Intratumoral Tigilanol Tiglate in Soft Tissue Sarcoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating the efficacy of intratumoral tigilanol tiglate in soft tissue sarcoma and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• tigilanol tiglate (tigilanol tiglate)

Snippet

Sponsor: QBiotics Group Limited | Conditions: Soft Tissue Sarcoma | Phase 2 | Status: RECRUITING